Clinical Trial Update: Efficacy of TQB2102 Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer. [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant trial comparing TQB2102 to TCbHP in HER2-positive early breast cancer; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• TCbHP
• TQB2102

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Breast Cancer, HER2 + Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING